ArticlePharmacoEconomics2023
Living Health Technology Assessment: Issues, Challenges and Opportunities.
Article in PharmacoEconomics, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers, 3 of them syntheses that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
21 citing papers in PubMed, 3 syntheses or guidelines pooled it.
- The Use of EQ-5D in the Middle East and North Africa Region: A Systematic Literature Review.PharmacoEconomics · 2025Pooled it
- Issues, Challenges and Opportunities for Economic Evaluations of Orphan Drugs in Rare Diseases: An Umbrella Review.PharmacoEconomics · 2024Pooled it
- Economic evaluations of artificial intelligence-based healthcare interventions: a systematic literature review of best practices in their conduct and reporting.Frontiers in pharmacology · 2023Pooled it
- Methods in Systematic Reviews of Health Economic Evaluations in Submissions to Health Technology Assessment Agencies: How Systematic Are They, and Does This Matter?PharmacoEconomics · 2026Review
- Action Plan to Better Approximate Reality in Cost-Effectiveness Analyses.Applied health economics and health policy · 2026Article
- Prior Authorization for Sacral Nerve Stimulation in the Era of WISeR: Evaluation of U.S. Payer Coverage Policies.Neurourology and urodynamics · 2026Article
- A life-cycle approach to digital health technology assessment.International journal of technology assessment in health care · 2026Review
- Mechanisms to enhance the use of living evidence syntheses in health policy: Reflections from key informants globally.Health research policy and systems · 2026Article
- Human-in-the-Loop Artificial Intelligence System for Systematic Literature Review: Methods and Validations for the AutoLit Review Software.Cochrane evidence synthesis and methods · 2025Article
- Integration of Generative AI with Human Expertise in HEOR: A Hybrid Intelligence Framework.Advances in therapy · 2025Review
- How was published evidence used in model-based cost - utility analysis for lung cancer?Health economics review · 2025Article
- Enhancing systematic literature reviews with generative artificial intelligence: development, applications, and performance evaluation.Journal of the American Medical Informatics Association : JAMIA · 2025Article
- A Framework for Using Cost-effectiveness Analysis to Support Pricing and Reimbursement Decisions for New Pharmaceuticals in a Context of Evolving Treatments, Prices, and Evidence.PharmacoEconomics · 2025Article
- Navigating barriers to health technology assessment development in Iran: a qualitative exploration of stakeholder perspectives.Archives of public health = Archives belges de sante publique · 2025Article
- Ethical challenges for Health Technology Assessment (HTA) in the evolving evidence landscape.International journal of technology assessment in health care · 2024Review
- Consumer engagement in living evidence "a beautiful opportunity": International qualitative study with patients and methodologists.Clinical and public health guidelines · 2024Article
- A Prototype Software Framework for Transferable Computational Health Economic Models and Its Early Application in Youth Mental Health.PharmacoEconomics · 2024Article
- An operationalization framework for lifecycle health technology assessment: a Health Technology Assessment International Global Policy Forum Task Force report.International journal of technology assessment in health care · 2024Review
- Lifecycle HTA: promising applications and a framework for implementation. An HTAi Global Policy Forum Task Force report.International journal of technology assessment in health care · 2024Review
- The Critical Intersect of Regulations, Health Technology Assessment, and Drug Safety Assessments.Drug safety · 2024Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
Abstract
Health technology assessments (HTAs) are typically performed as one-off evaluations and can potentially become out-of-date due to the availability of new data, new comparators, or other factors. Recently, living approaches have been applied to systematic reviews and network meta-analyses to enable evidence syntheses to be updated more easily. In this paper, we provide a definition for 'Living HTA' where such a living approach could be applied to the entire HTA process. Living HTA could involve performing regular or scheduled updates using a traditional manual approach, or indeed in a semi-automated manner leveraging recent technological innovations that automate parts of the HTA process. The practical implementation of living HTA using both approaches (i.e., manual approach and using semi-automation) is described along with the likely issues and challenges with planning and implementing a living HTA process. The time, resources and additional considerations outlined may prohibit living HTA from becoming the norm for every evaluation; however, scenarios where living HTA would be particularly beneficial are discussed.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.